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Serotype G9 may be the fifth most common human rotavirus serotype, after
serotypes G1 to G4. In three cross-sectional studies of childhood diarrhea,
we have detected serotype G9 rotaviruses for the first time in Libya, Kenya,
and Cuba. Serotype G9 constituted 27% of all rotaviruses identified,
emphasizing the reemergence of serotype G9 and suggesting that future
human rotavirus vaccines will need to protect against disease caused by
this serotype.
Group A rotaviruses are firmly established as the most
important etiologic agents of dehydrating gastroenteritis in
infants and young children worldwide (1). Severe rotavirus
disease is preventable by vaccination. The expected impact
of rotavirus vaccines in reducing disease and death from
rotavirus infection will be most evident in developing coun-
tries, where rotavirus causes up to 500,000 childhood deaths
annually (2).
Rotaviruses are nonenveloped viruses whose genome
comprises 11 segments of double-stranded RNA (dsRNA),
contained in the core of the mature, triple-layered particle
(1). Rotavirus serotypes are determined by neutralizing anti-
body responses to each of the two outer capsid proteins, VP7
(termed G serotype) and VP4 (termed P serotype). Ten G
serotypes and 7 P serotypes have been identified in humans
(1). Since serotypes G1, G2, G3, and G4 together account for
>80% of global human rotavirus strains, some vaccines aim
to provide serotype-specific protection against these four
serotypes (1). However, in certain geographic settings, other
G types (e.g., G5, G8, and G9) may be epidemiologically
important (1). 
Since their first report in 1987 in the United States,
rotaviruses of serotype G9 had been rarely detected in the
human population (3). Since 1995, however, serotype G9 has
been documented in India, Brazil, Italy, the United States,
Bangladesh, Malawi, the United Kingdom, France, and Aus-
tralia (4). Recent reports from Ireland (5), the Netherlands
(6), Japan (7), and Thailand (8) further emphasize the wide
geographic distribution of this serotype. We recently charac-
terized rotavirus strains detected during studies of diarrheal
disease in children in Libya, Kenya, and Cuba. We identified
serotype G9 rotaviruses in each of these countries, providing
further evidence that serotype G9 has reemerged as a glo-
bally important human serotype.
The Study
In all three studies, fecal specimens were collected from
children <5 years of age who were hospitalized for treatment
of acute gastroenteritis. In Libya, the study was conducted
during April and May 2000 and was based at the Misurata
Teaching Hospital in Misurata. The samples from Kenya
were collected from January to March 2000 from children
hospitalized at the Gertrude’s Garden Children’s Hospital in
Nairobi. The third group of samples was obtained during
April and May 2000 from children hospitalized at the Centro
Havana Children’s Hospital, Havana, Cuba.
Fecal specimens were stored at 4°C until they were
shipped to the University of Liverpool. Rotavirus infections
were diagnosed by negative stain electron microscopy. All
rotavirus-positive samples were selected for rotavirus strain
characterization. 
Rotavirus dsRNA was extracted from fecal samples by a
guanidine and silica method (9). The 11 dsRNA segments
were separated by polyacrylamide gel electrophoresis and
stained with silver to identify the two main RNA profiles, or
electropherotypes (long and short). Rotavirus G and P types
were determined by using hemi-nested reverse transcrip-
tion-polymerase chain reaction (RT-PCR). The genotyping
methods, which serve as a proxy for serotype determination
by virus neutralization, have been described (9,10). A combi-
nation of consensus and type-specific primers have been
designed to amplify strains of the common rotavirus sero-
types, as well as some uncommon serotypes (9-12).
Briefly, for G typing, consensus primers 9con1 and 9con2
were used in a first-round RT-PCR (10 cycles) to generate a
905-bp VP7 gene fragment; 9con1 was then used in a second-
round PCR (30 cycles) with type-specific primers 9T-1 (G1),
9T-2 (G2), 9T-3P (G3), 9T-4 (G4), MW8 (G8), and 9T-9B (G9).
For P typing, consensus primers con2 and con3 were used in
a first-round RT-PCR (10 cycles) to generate a 877-bp frag-
ment of gene 4; con3 was then used in a second-round PCR
(30 cycles) with type-specific primers 1T-1 (P[8]), 2T-1 (P[4]),
3T-1 (P[6]), 4T-1 (P[9]), and 5T-1 (P[10]). For strains that
failed to give type-specific products, alternative typing prim-
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ers were used that included a G1-specific primer (nac9) and
a P[8]-specific primer (nac10). These primers were designed
at the 9T-1 and 1T-1 primer binding regions, respectively, of
divergent serotype G1 and P[8] lineages that we have
recently identified in Malawi (13). Strains that could not be
typed even by using the alternative primers were recorded
as nontypeable (NT). RT-PCR products were resolved by
electrophoresis on 2% agarose gel and then visualized by
ultraviolet illumination after ethidium bromide staining.
Thirty-five (48%) rotaviruses were detected in 73 fecal
samples from Libyan children. These comprised strains P[8],
G1 (n = 16, 46%); P[8], G9 (n = 12, 34%); P[6], G1 (n = 4,
11%); P[4], G2 (n = 1, 3%); and P[NT], G1 (n = 2, 6%). Seven
serotype G1 strains and 23 genotype P[8] strains required
alternative primers for efficient typing. Long electrophero-
type profiles were visualized for serotype G1 and G9 strains,
and the single serotype G2 strain had a short profile. 
Twenty (41%) rotaviruses from 49 cases of diarrheal dis-
ease were characterized from Kenya. The most commonly
identified strain was P[8], G1 (n = 12, 60%), followed by P[8],
G9 (n = 2, 10%). One strain (5%) of each of the following gen-
otypes made up the rest: P[6], G9; P[4], G8; P[6], G1; P[8],
G3; P[NT], G1; and P[NT], G8. Alternative primers were
required to type three serotype G1 strains and eight geno-
type P[8] strains. Overall, serotype G9 was detected in three
(15%) of specimens. Most strains, including serotype G1 and
G9 strains, had long electropherotype profiles. Both serotype
G8 strains had short electropherotypes.
Five (9%) rotaviruses were detected in 55 fecal samples
from Cuban children. Three P[8], G4 strains, a single P[8],
G9 strain, and a single P[NT], G4 strain were identified. All
strains had long electropherotype profiles.
The G9 specificities of representative serotype G9
strains from Libya and Kenya and the single Cuban G9
strain were confirmed by partial nucleotide sequencing of
full-length RT-PCR VP7 gene products obtained by using
primer pair beg9/end9 (10) (data not shown).
Age data were available for 54 (90%) of the children,
including 16 children infected with serotype G9 rotaviruses
and 38 infected with other rotavirus strains. The age distri-
bution of serotype G9-infected children (median 15 months;
range 6-30 months) was similar to that of children excreting
other rotavirus serotypes (median 11.5 months; range 4-57
months).
Conclusions
These three small cross-sectional studies have docu-
mented the presence of serotype G9 in each of the countries
surveyed. Serotype G9 was the second most commonly
detected serotype in Libya and Kenya, accounting for 34%
and 15%, respectively, of G types in those countries. It was
also the only G type, apart from serotype G4, to be detected
in five samples from Cuba. No previous studies have charac-
terized rotaviruses from either Libya or Cuba. A recent
study examined the distribution of rotavirus serotypes in
Kenya (14), but to our knowledge this is the first time that
serotype G9 has been reported there. Furthermore, this is
only the second published report of serotype G9 from Africa,
following an earlier report from Malawi (12).
Many serotype G1 and P[8] strains from Libya and
Kenya could be typed only by using alternative typing prim-
ers, since type-specific products could not be obtained for
them with conventional primers. Variation in the sequence of
the primer binding region of common serotypes, as well as
the occurrence of uncommon serotypes, should be considered
when nontypeable rotaviruses are identified in strain char-
acterization studies (13).
Most serotype G9 strains in these studies had long elec-
tropherotypes and P[8] VP4 specificity, but a single P[6] VP4
type (also with a long electropherotype) was associated with
a serotype G9 strain in Kenya. The reference serotype G9
strains, WI61 (3) and F45 (15), have long electropherotypes
and P[8] VP4 specificity. More recently, serotype G9 has been
associated with both long and short electropherotypes and a
variety of P types including P[6], P[8], and P[11], and molec-
ular characterization of a representative sample of these
strains suggests that genomic reassortment played an
important role in their evolution (4). 
The recent upsurge in published reports of serotype G9
rotaviruses may partly reflect more widespread application
of improved methods for their detection. However, increasing
evidence indicates that serotype G9 has reemerged in the
human population and has recently been imported into cer-
tain countries. For example, molecular characterization of
serotype G9 strains identified in the United Kingdom dem-
onstrated a high degree of sequence homology among VP7
genes, suggesting that they had been imported relatively
recently (16). The observation that children in the United
Kingdom infected with serotype G9 strains were older and
had more severe disease than children infected with other
serotypes supports this hypothesis, since the population
would lack neutralizing antibody to this serotype (17). We
did not find serotype-specific age differences in this study;
however, the numbers may have been too small to allow
detection.
More recently, a protracted outbreak of rotavirus diar-
rhea caused by P[6], G9 strains occurred in a neonatal ward
in the Netherlands, which was surprising since rotavirus
infection of neonates is typically asymptomatic (6). The
unusually high proportion of symptomatic cases may be
partly explained by lack of protective, passively acquired
maternal neutralizing antibodies to serotype G9 in the
affected neonates, since G9 had not previously been identi-
fied in the Netherlands (6).
Although our studies are limited by small sample size,
we have demonstrated the presence of serotype G9 in each of
the three countries, and this serotype represented 16 (27%)
of 60 strains overall. These and other recent data suggest
that serotype G9 has emerged as the fifth most common glo-
bal rotavirus serotype. Continued rotavirus surveillance will
be necessary to monitor the spread and persistence of this
serotype. Future rotavirus vaccines will likely need to pro-
vide adequate protection against disease caused by serotype
G9 rotaviruses.
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